Magnetothermally Responsive Mesoporous Silica Nanocarriers: Materials Design, Thermoresponsive Gates and Controlled Drug Release
Nanomaterials · 18.08.2026 · 16 (16) · 1018
DOI: 10.3390/nano16161018 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nanomaterials, online erschienen am 18.08.2026. Verfasst von Juliana Jesus und 4 weiteren Autor:innen. Beteiligte Einrichtung: i3N and Department of Physics, University of Aveiro, Campus Universitário de Santiago, 3810-193 Aveiro, Portugal. Die Arbeit nennt 150 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Foundation for Science and Technology, FCT—Fundação para a Ciência e a Tecnologia, I.P., Associate Laboratory I3N.
Abstract (Originalsprache)
Magnetothermally responsive nanocarriers represent a promising platform for spatio-temporally controlled drug delivery by combining alternating magnetic field (AMF)-induced heating with thermally triggered cargo release. Among the available architectures, magnetite-core/mesoporous-silica-shell (Fe3O4@mSiO2) nanoparticles functionalized with thermoresponsive polymer gatekeepers are particularly attractive. These systems integrate a magnetic heat source, a mesoporous drug reservoir, and temperature-dependent control of pore accessibility. This review examines the fundamental principles of magnetic hyperthermia, including heat-generation mechanisms, specific absorption rate (SAR), intrinsic loss power (ILP), AMF parameters and safety, and the interplay between Néel and Brownian relaxation. It also critically discusses core–shell synthesis and architecture, drug-loading strategies, PNIPAM-, PNVCL-, and other LCST-type gatekeepers, and the physicochemical characterization required to validate the complete nanocarrier. Evidence for combined magnetic hyperthermia and chemotherapy is assessed together with hemocompatibility, immunogenicity, oxidative stress, biodistribution, degradation, long-term retention, and clearance. Although promising magnetothermal release and therapeutic effects have been reported, evidence remains dominated by in vitro studies, with limited in vivo validation. Current clinical experience concerns locally administered iron-oxide hyperthermia rather than complete thermoresponsive Fe3O4@mSiO2 drug-delivery systems. Translation will require standardized magnetothermal and release testing, reproducible scale-up, validated sterilization and endotoxin control, component-resolved pharmacokinetics, and integrated development of the nanocarrier and AMF applicator.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- i3N and Department of Physics, University of Aveiro, Campus Universitário de Santiago, 3810-193 Aveiro, Portugal.
- Coimbra Institute for Clinical and Biomedical Research (iCBR) Area of Environment Genetics and Oncobiology (CIMAGO), Institute of Biophysics, Faculty of Medicine, University of Coimbra, Azinhaga de Santa Comba, Pólo III…
- Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, Rua Larga, 3004-504 Coimbra, Portugal.
- Clinical Academic Center of Coimbra (CACC), Praceta Professor Mota Pinto, 3004-561 Coimbra, Portugal.
- Centre for Mechanical Engineering, Materials and Processes (CEMMPRE), Advanced Production and Intelligent Systems Associated Laboratory (ARISE), Department of Mechanical Engineering, University of Coimbra, Rua Luís Reis…
ORCID-Profile: Juliana Jesus, Manuel Graça, Ana Salomé Pires, Susana Devesa, Sílvia Soreto Teixeira
Förderung
- Foundation for Science and Technology
- FCT—Fundação para a Ciência e a Tecnologia, I.P.
- Associate Laboratory I3N
Zitieren
APA
Jesus, J., Graça, M., Pires, A. S., Devesa, S., & Teixeira, S. S. (2026). Magnetothermally Responsive Mesoporous Silica Nanocarriers: Materials Design, Thermoresponsive Gates and Controlled Drug Release. Nanomaterials, 16(16), 1018. https://doi.org/10.3390/nano16161018
Vancouver
Jesus J, Graça M, Pires AS, Devesa S, Teixeira SS. Magnetothermally Responsive Mesoporous Silica Nanocarriers: Materials Design, Thermoresponsive Gates and Controlled Drug Release. Nanomaterials. 2026;16(16):1018. doi:10.3390/nano16161018
BibTeX
@article{Jesus2026,
author = {Jesus, Juliana and Graça, Manuel and Pires, Ana Salomé and Devesa, Susana and Teixeira, Sílvia Soreto},
title = {Magnetothermally Responsive Mesoporous Silica Nanocarriers: Materials Design, Thermoresponsive Gates and Controlled Drug Release},
journal = {Nanomaterials},
year = {2026},
volume = {16},
number = {16},
pages = {1018},
doi = {10.3390/nano16161018}
}
EUVIMED